Magstim and NeuroStar come from different TMS traditions. Magstim built its reputation in research labs worldwide — it’s the system you’ll find in thousands of published studies. NeuroStar built its reputation in clinical practice — it’s the system you’ll find in US psychiatry offices. Comparing them means deciding what matters most for your situation.
What You’ll Learn
- Technical differences in coil design and configurability
- Protocol support on each platform
- Research vs clinical pedigree
- US availability and insurance implications
The Core Difference: Research vs Clinical
Magstim is UK-based, founded in the 1990s, and has been the de facto standard for TMS research globally. The Rapid² platform is highly configurable with multiple coil options (figure-8, circular, double cone) and precise parameter control. It’s the system that generated most of the foundational TMS research data.
NeuroStar is US-based (Neuronetics), built specifically for clinical use, and holds the largest commercial TMS install base in the US. It prioritizes streamlined clinical workflow, patient comfort, and practice management over configurability.
Coil Design and Configuration
Magstim’s Rapid² supports a range of coil geometries that can be swapped out for different clinical and research applications. This flexibility is valuable for academic centers treating multiple conditions or running investigator-initiated studies.
NeuroStar uses a proprietary iron-core figure-8 coil with built-in contact sensing that automatically verifies consistent coil placement session-to-session. The system is less configurable but more automated for routine clinical use.
FDA Clearances
| Indication | NeuroStar | Magstim |
|---|---|---|
| MDD Depression | 2008 (first) | Cleared |
| Anxious Depression | 2021 | No specific clearance |
| OCD | No | No |
| Smoking Cessation | Yes | No |
NeuroStar leads in labeled indications. Magstim’s clinical evidence base comes largely from research protocols rather than industry-sponsored trials.
US Availability
NeuroStar dominates the US commercial market with 1,000+ installed locations. Magstim is common in academic medical centers and TMS research centers but has a smaller commercial footprint. Most private practice TMS clinics use NeuroStar.
For Patients
Both deliver FDA-cleared, evidence-based TMS for depression. When protocols are matched, outcomes are equivalent. Your provider’s expertise and the specific protocol they use will affect your outcome far more than which company built the machine.
For most patients, NeuroStar is more accessible: easier to find a provider, more established insurance relationships, and more streamlined clinical workflow. Magstim is a strong option at academic or research-oriented clinics.
Search TMS providers or explore device comparisons.
Key Takeaways
- Magstim is the global research standard for TMS
- NeuroStar dominates the US clinical/commercial market
- Both deliver equivalent outcomes for standard depression treatment
- NeuroStar has more labeled FDA indications
- Magstim offers greater coil configuration flexibility
Find a TMS Clinic
Search verified providers by device, location, and insurance coverage.